Pharmacologic therapies are evaluated through a combination of preclinical studies, clinical trials, and post-marketing surveillance. Clinical trials, often conducted in phases, assess the safety, efficacy, and optimal dosing of new therapies. Post-marketing surveillance monitors the long-term safety and effectiveness of therapies once they are available to the general population.
